Bernstein keeps USD 3.55 target for Ambev stock

Published on 10/20/2026 at 20:31 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Q2 normalized EBITDA grew 8.9 percent in the period ended June 30, 2026. Ambev stock costs EUR 2.96 on October 20, 2026 at 8:23 p.m. CEST.

Analyst target and results date

Bernstein maintained a USD 3.55 target and Hold rating for Ambev on October 15, 2026.
Normalized EBITDA increased 8.90 percent in the second quarter of 2026.
Ambev stock traded at EUR 2.96 at Lang & Schwarz on October 20, 2026 at 8:23 p.m. CEST.

ABEV, US02319V1035, Illustration mit AI erstellt.

Bernstein maintained a Hold rating and a USD 3.55 price target for Ambev on October 15, 2026, putting the target 7.25 percent above the NYSE quote of USD 3.31 at 2:30 p.m. ET. Markets Insider reported the analyst action. Ambev stock was trading at EUR 2.96 at Lang & Schwarz on October 20, 2026 at 8:23 p.m. CEST.

Operating growth sets the baseline

Ambev's second-quarter 2026 normalized EBITDA rose 8.90 percent to BRL 6.40 billion, while normalized earnings per share increased 24.20 percent year over year. The figures were discussed in the company's second-quarter earnings call dated July 30, 2026. Yahoo Finance carried the transcript. Net revenue increased 6.00 percent in the quarter, and operating cash flow reached BRL 7.90 billion in the first half of 2026.

NYSE valuation and trading position

Stock Analysis identifies Ambev as a NYSE-listed company under ticker ABEV, with reporting currency BRL and a fiscal year ending in December. The NYSE quote was USD 3.31 on October 20, 2026 at 2:30 p.m. ET, versus a 52-week range of USD 2.18 to USD 3.45. The market capitalization was USD 51.6 billion on that date, and the price-to-earnings ratio was 16.15.

The valuation picture is mixed rather than uniform. Bernstein's USD 3.55 target is above the NYSE quote, while the broader operating record includes 8.90 percent normalized EBITDA growth and 24.20 percent normalized earnings-per-share growth for the second quarter. Those figures give investors a concrete way to weigh the target against reported execution.

October 29 results date

Ambev's investor-relations calendar lists third-quarter 2026 results for October 29, 2026, before the opening of the B3 and NYSE. The company also scheduled an English-language webcast for 11:30 a.m. New York time on that date. Ambev published the date on its investor-relations page.

What the target means for valuation

The Bernstein target implies 7.25 percent upside from the USD 3.31 NYSE quote, while the next scheduled report provides the next dated operating checkpoint. The second-quarter figures also provide a comparison point: normalized EBITDA growth of 8.90 percent came alongside normalized earnings-per-share growth of 24.20 percent.

Price and company details

Ambev stock was trading at EUR 2.96 at Lang & Schwarz on October 20, 2026 at 8:23 p.m. CEST. The euro quote is the latest market indication for investors in Germany, while the NYSE listing remains the company's primary exchange.

The further course of trading is shown by the continuously updated real-time quote of Ambev stock.